Ahluwalia Contracts (India) AHLUCONT

Summary

Ahluwalia Contracts' PBILDT margin has gone from a mid-single-digit, medium-term "normal" of 9.93% in FY24 to 8.21% in FY25, back up to roughly 10% in FY26 on H2 execution catch-up — and then collapsed to just 4.29% in Q1 FY27, down from 8.59% in the same quarter a year earlier. Revenue still grew 12.03% YoY to ₹1,125.81 crore, but PAT fell 77.65% YoY to only ₹11.42 crore. Management's own explanation is a 35-40% increase in minimum wages across the National Capital Region (Haryana/UP), which affects roughly half of ACIL's order book by value; project delays and higher staff costs added to the hit. Most tellingly, management explicitly withdrew its prior guidance of double-digit EBITDA margins for FY27 while holding revenue-growth guidance at 12-15% and cutting full-year order-inflow guidance to ₹4,000-5,000 crore from a prior ₹8,000 crore target. This is the single most negative margin story found anywhere in this report, and it is a labour-cost, not a one-off, shock.

The rating-agency angle sharpens the concern rather than softening it. CARE Ratings reaffirmed CARE AA-/Stable (long-term) and CARE A1+ (short-term) on ₹2,515 crore of bank facilities as recently as 30 December 2025 — but that rationale explicitly states its own negative-rating trigger as "contraction in profitability margins below 8% on a sustained basis." The Q1 FY27 print of 4.29% sits well below that threshold. This research could not find any CARE (or other agency) rating action dated after the Q1 FY27 results (disclosed ~August 2026) as of the digest's 20 September 2026 research date — meaning a downgrade risk that, by the rating agency's own stated criteria, already looks live and unresolved. The stock has fallen roughly 45-46% from its 52-week high of ₹1,078 to around ₹585, and a trailing P/E of ~17.4x looks cheap only if the reader ignores exactly why it has de-rated.

ACIL's portfolio explicitly lists data centres as a project type, and this research confirmed two named DC EPC contracts — AdaniConneX Noida (~₹209 crore, FY2022-23) and IFTAS Bhubaneswar (~₹169 crore, announced ~March 2023). Both are 3+ years old. Despite targeted searches for newer wins with Airtel Nxtra, STT GDC, Yotta or CtrlS, none were found, and the order-book mix has meanwhile shifted hard toward Gurgaon/NCR residential work (23% to 44% of the order book in one year) and private-sector contracts generally (52% to 69%). ACIL should be read as a company with historical, not continuing, data-center exposure — not as an active beneficiary of the current AI-driven data-center capex cycle.

Net: a SELL, target ₹476 (-18.6% from ₹585). The margin compression is structural — roughly half the order book carries NCR labour-cost exposure that will not reverse on its own — and the dominant near-term risk is not general execution risk but the real possibility of a confirmed rating-agency downgrade given CARE's own already-breached threshold.

• A large, multi-year order book. ₹20,663.52 crore as of 30 June 2026 (Q1 FY27), to be executed over roughly the next 3.5 years, geographically diversified across 15 Indian states and Nepal.
• Genuinely low leverage and strong liquidity. TOL/TNW of 1.06x (FY25); unencumbered cash and bank balances of ₹892.60 crore as of 30 Sep 2025; average fund-based working-capital utilisation of only ~7% over the 12 months to Sep 2025 — the company funds working capital mainly through mobilisation advances and creditors rather than bank debt.
• An AA- long-term credit rating, reaffirmed as recently as 30 December 2025, on ₹2,515 crore of bank facilities — though see "What gives us pause" below on why this reaffirmation predates the risk this report flags as live.
• Board composition meets the applicable SEBI LODR independent-director threshold. With Chairman and Managing Director roles combined in founder-promoter Bikramjit Ahluwalia, SEBI LODR requires at least half the board to be independent; ACIL's board (4 of 8 directors independent, including one woman, a retired IAS officer) meets this exactly, per CARE Ratings' own governance note.
• Demonstrated capacity to recover execution momentum: Q2 FY26 PAT jumped 105% YoY as fixed-cost absorption improved with higher revenue — evidence the business can claw back margin when volumes cooperate, though Q1 FY27 shows that recovery is not guaranteed against a structural cost shock.
• ISO 14001, ISO 45001 and ISO 27001 certifications, a formal workplace-safety and anti-harassment policy, and zero whistleblower/anti-corruption grievances reported in FY25.

• The PBILDT margin collapse is the central reason for this report's SELL call. 9.93% (FY24) → 8.21% (FY25) → ~10% (FY26) → 4.29% (Q1 FY27), driven by a 35-40% NCR minimum-wage hike hitting a labour-intensive cost base across roughly half the order book by value. This is a structural, not one-off, exposure.
• Management explicitly withdrew its prior double-digit EBITDA-margin guidance for FY27 — taken here at face value as a genuine negative signal, not a conservative sandbag. Order-inflow guidance was simultaneously cut to ₹4,000-5,000 crore from a prior ₹8,000 crore target.
• CARE's own stated negative-rating trigger (margin below 8% on a sustained basis) already looks breached by the 4.29% Q1 FY27 print, yet the most recent CARE rationale located (30 December 2025) predates the Q1 FY27 results, and no post-results rating action was confirmed as of this research's 20 September 2026 date. This is a live, unresolved downgrade risk, flagged explicitly rather than assumed away.
• The two named data-center contracts are stale. AdaniConneX Noida (~₹209 crore) and IFTAS Bhubaneswar (~₹169 crore) both date to FY2022-23; no newer data-center win was found despite targeted searching, and order-book mix has shifted toward NCR/Gurgaon residential work (23%→44% in one year) — ACIL is not, on current evidence, an active beneficiary of the present data-center capex cycle.
• Working-capital intensity is rising. Gross Current Asset days rose from 205 (FY24) to 210 (FY25); collection days extended from 77 days (FY22) to 136 days (FY25); interest coverage fell from 8.01x (FY24) to 5.98x (FY25) and total debt/PBILDT rose from 1.65x to 2.13x over the same period.
• A SEBI warning letter (9 July 2024) for a 270-day gap between Risk Management Committee meetings, breaching Regulation 21(3C)'s 180-day limit — characterised by the company as unintentional and remediated, but a confirmed regulatory lapse nonetheless.
• NCR/NGT construction-ban exposure. CARE itself flags National Green Tribunal-driven construction bans in NCR as a credit risk given the order book's rising NCR concentration; ICICI Securities separately cited "stricter construction curbs in NCR in Q3" as a near-term risk post-Q1FY27.

• Any CARE (or other agency) rating action dated after the Q1 FY27 results — the single most important, live, unresolved item for this stock.
• H2 FY27 execution and margin trajectory — whether the fixed-cost-absorption recovery seen in Q2 FY26 repeats, or whether the NCR wage shock proves durable across the full year.
• NCR/NGT construction-curb developments into Q3, as separately flagged by ICICI Securities.
• Whether ACIL wins any new data-center EPC contract — would be the first such win since FY2022-23 and would materially change the DC-exposure read on this stock.
• Progress against the reduced FY27 order-inflow guidance (₹4,000-5,000cr vs. the prior ₹8,000cr target).

• Rating-downgrade risk (dominant). CARE's own stated negative trigger (margin below 8% on a sustained basis) already appears breached by the Q1 FY27 print; no post-results rating action has been confirmed. This, not general execution risk, is this report's primary near-term concern.
• Structural NCR labour-cost risk across roughly half the order book — a wage-inflation shock, not a project-specific or one-off item, and one management itself has acknowledged by withdrawing guidance.
• Working-capital and leverage drift, with GCA and collection days rising and interest coverage falling even before the Q1 FY27 shock.
• NGT/construction-ban risk in NCR, given the order book's rising geographic concentration there.
• Data-center-thesis risk: no confirmed recent DC win exists: treating ACIL as a current data-center capex beneficiary would be a misreading of the evidence in this digest.

We derive trailing EPS from the company's own disclosed trailing P/E rather than from FY26 audited PAT, since the FY26 figure predates — and is therefore flattered relative to — the Q1 FY27 margin collapse: CMP ₹585 ÷ disclosed trailing P/E of 17.4x gives trailing EPS of ~₹33.62, a base that already reflects the weak Q1 FY27 quarter within the trailing twelve months. Given management's explicit withdrawal of double-digit- margin guidance and the absence of any confirmed post-Q1FY27 rating action, we do not assume a return to prior margin economics; instead we construct FY27E EPS scenarios anchored to this trailing base, and apply target multiples that reflect — rather than assume away — the live downgrade risk:

Base case rounded to ₹476. The bear case assumes the NCR wage shock persists at close to Q1 FY27 intensity through FY27 and a rating downgrade materialises, compressing the multiple below even the current depressed 17.4x. The bull case assumes an H2-style margin recovery (as seen in Q2 FY26) and no adverse rating action, still only recovering to roughly the pre-shock multiple. Named brokerage coverage found in this research is more constructive: ICICI Securities downgraded ACIL to Hold with a ₹780 target post-Q1FY27 (~Aug/Sep 2026), and Prabhudas Liladhar carries a Buy at ₹930 — but the latter's date could not be confirmed and likely predates the Q1 FY27 results, and a further TipRanks-style aggregator consensus of ~₹988 almost certainly predates the shock as well. This report treats the ICICI Hold/₹780 view as the most current available benchmark, and still arrives at a more cautious base case, on the view that the live, unconfirmed rating-downgrade risk this digest identifies is not yet fully reflected in that or any other external target found.

*Q1 FY26 PAT of ₹51.10cr is back-calculated from the disclosed 77.65% YoY decline to a Q1 FY27 PAT of ₹11.42cr; not independently sourced as a standalone reported figure in this digest. Source: screener.in (18-20 Sep 2026 fetch, consolidated basis), cross-checked against CARE Ratings' 30 Dec 2025 rationale (standalone basis) and Investing.com/Yahoo Finance/BusinessUpturn Q1 FY27 earnings-call coverage (~Aug 2026). Order book: ₹20,663.52cr as of 30 Jun 2026 (Q1 FY27), per Investing.com/BusinessUpturn.